Stat

AbbVie Takes the Leap: Why the $2.5 B Buy‑out of Apogee Therapeutics Could Redefine Immunology

Pharma & Biotech M&A Surge Hits $123 Billion in 2026

Pharma and Biotech Dealmaking Hits $123 Billion in 2026

The Great Data Divide: Navigating the Complexities of Clinical Trial Transparency

When Clinical Trial Data Becomes Too Much: Finding the Sweet Spot

The Persistent Quest: Unpacking Concerns Around Patrick Soon-Shiong's Pancreatic Cancer Ambitions and Abivax

The Gathering Storm: Senate Democrats Brace for RFK Jr.'s Vaccine Policies

Europe's Most Favored Nation Drug Pricing Push: A Looming Challenge for Innovation and Access

Boehringer Ingelheim’s Survodutide Shows Promise in Late‑Stage Obesity Trials

Boehringer Ingelheim’s Survodutide Shows Strong Weight‑Loss Results in Late‑Stage Trial

The Unseen Scars: When Hope Fades and Oncologists Grieve

Medicare’s $50 GLP‑1 Weight‑Loss Plan: What the Numbers Really Mean

Medicare’s $50 Weight‑Loss Drug Plan: What the Numbers Really Mean

A New Chapter for Squamous Cell Lung Cancer: Harmoni’s Breakthrough at ASCO 2026

Day 2 at ASCO 2026: Fresh Data from BioNTech‑Pfizer, Kelun, Merck and Insights from Dr. Pazdur

Day 2 Highlights from ASCO 2026: Breakthroughs from BioNTech, Pfizer, Kelun, Merck and Insights by Dr. Eric Pazdur

A Glimmer of Hope: Rewriting the Future of Pancreatic Cancer Treatment

The Unveiling of Trump's Most Favored Nation Drug Pricing Secrets

FDA Chief Kyle Diamantas Hails NIH’s Quick Fix to Leadership Gap Amid DC Health Concerns

Utah’s Doctronic AI Experiment Shows Early Promise in Transforming Patient Care

Kyle Diamantas Shines as Acting FDA Commissioner, Winning Trust Across the Board

Beyond the Hype: A Biotech CEO's Grounded View on AI in Drug Development

The Unseen Hand: How Pharma Giants Shape Policy Through Academic Influence

The Quiet Influence: Pharma's Play in Shaping Policy

Beyond the Budget: Charting a New Course for the NIH in a Post-Pandemic World

TrumpRx’s Generic Drug Push Falters as Cassidy’s FDA Battle Deepens

The Silent Threat: How Alcohol Impacts Unborn Babies

A Great Divide: American Biotech Grapples with the Ascendant Chinese Pharma Sector

Battle Lines Drawn: UK Health Advocates Prepare for Legal Fight Over US Pharma Trade Deal

Hantavirus on the High Seas: How a Cruise Ship Outbreak Echoed COVID‑19 Panic and Spawned Wild Theories

A Cruise Ship Hantavirus Outbreak Sparks COVID‑Era Flashbacks and Wild Conspiracy Theories

The FDA's Uphill Battle: Reclaiming Trust and Scientific Rigor in a New Era

Navigating the Dragon's Den: China's Evolving Role in Global Biotech

Dr. Nicole Saphier Unpacks Her Vision for Public Health as Surgeon General Nominee

Unpacking Tomorrow's Cancer Fight: Key Insights from AACR 2026

A Paradigm Shift: CAR T-Cell Therapy Offers New Hope for Stiff Person Syndrome

A New Dawn for Pancreatic Cancer: Unpacking the Revolutionary Science from AACR 2026

A Renewed Sense of Hope: Roche's Ocrevus Continues to Impress in MS Care

The Ripple Effect: How a Purdue Pharma Ruling Could Unsettle Pharma Settlements